Pfizer Zyrtec-D Labeled "Rx-only" Pending Antihistamine OTC Switch Decision

13 Aug 2001

• By The Pink Sheet

Pfizer's antihistamine/decongestant combination product Zyrtec-D has been approved as "Rx-only" pending decision on over-the-counter switch status of the antihistamine class.

Pfizer Zyrtec-D Labeled "Rx-only" Pending Antihistamine OTC Switch Decision

More from Archive

More from Pink Sheet